JJIJ
Johnson & Johnson Innovation - JJDC Portfolio holdings
AUM
$978M
This Quarter Return
+99.27%
1 Year Return
+101.76%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$277M
AUM Growth
–
Cap. Flow
+$277M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
99.93%
Holding
11
New
11
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Arrowhead Research
ARWR
|
$207M |
| 2 |
BiomX
PHGE
|
$20.7M |
| 3 |
Protagonist Therapeutics
PTGX
|
$17.3M |
| 4 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
$16.8M |
| 5 |
PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
|
$9.82M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.44% |
| 2 | Technology | 0.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Arrowhead Research
ARWR
$3.05B
| $207M | 74.59% | +3,260,869 | New | +$207M |
|
|
2
BiomX
PHGE
$14.3M
| $20.7M | 7.45% | +2,133,402 | New | +$20.7M |
|
|
3
Protagonist Therapeutics
PTGX
$3.67B
| $17.3M | 6.23% | +2,449,183 | New | +$17.3M |
|
|
PRVB
4
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $16.8M | 6.04% | +1,124,973 | New | +$16.8M |
|
|
PHAS
5
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $9.82M | 3.54% | +1,607,044 | New | +$9.82M |
|
6
Aldeyra Therapeutics
ALDX
$351M
| $3.46M | 1.25% | +594,834 | New | +$3.46M |
|
|
CSLT
7
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $1.08M | 0.39% | +811,295 | New | +$1.08M |
|
8
Senseonics Holdings
SENS
$374M
| $481K | 0.17% | +525,632 | New | +$481K |
|
9
Gyre Therapeutics
GYRE
$703M
| $456K | 0.16% | +66,951 | New | +$456K |
|
|
GNCA
10
DELISTED
Genocea Biosciences, Inc.
GNCA
| $298K | 0.11% | +143,964 | New | +$298K |
|
|
TCON
11
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $197K | 0.07% | +84,003 | New | +$197K |
|